[1] [1] SZEKANECZ Z, RATERMAN H G, PETHO Z, et al. Common mechanisms and holistic care in atherosclerosis and osteoporosis[J]. Arthritis Research & Therapy, 2019, 21(1): 15.

[2] [2] TAKASHI H, KAZUMASA K, HIROTADA M, et al. Loss of bone mineral density following sepsis using Hounsfield units by computed tomography[J]. Acute Medicine & Surgery, 2019, 6(2): 173-179.

[3] [3] L I N Q, K U M A R S, K A R I YAWA S A M U, e t a l. Human resistin induces cardiac dysfunction in pulmonary hypertension[J]. Journal of the American Heart Association, 2023, 12(6): e027621.

[4] [4] TRIPATHI D, KANT S, PANDEY S, et al. Resistin in metabolism, inflammation, and disease[J]. FEBS Journal, 2020, 287(15): 3141-3149.

[5] [5] CERVELLATI C, BONACCORSI G, BERGAMINI C M, et al. Association between circulatory levels of adipokines and bone mineral density in postmenopausal women[J]. Menopause, 2016, 23(9): 984-992.

[6] [6] GLOGOWSKA-SZELAG J, KOS-KUDLA B, MAREK B, et al. Assessment of selected adipocytokines in obese women with postmenopausal osteoporosis[J]. Endokrynologia Polska, 2019, 70(6): 478-483.

[7] [7] BILHA S C, BRANISTEANU D, BUZDUGA C, et al. Modifications in the spectrum of bone mass predictive factors with menopausal status[J]. Endocrine Research, 2018, 43(3): 176-185.

[8] [8] OH K W, LEE W Y, RHEE E J, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men[J]. Clinical Endocrinology, 2005, 63(2): 131-138.

[9] [9] TARIQ S, TARIQ S, KHALIQ S, et al. Serum resistin levels as predictor of low bone mineral density in postmenopausal women[J]. Health Care for Women International, 2021, 42(1): 82-91.

[10] [10] TARIQ S, TARIQ S, KHALIQ S, et al. Serum resistin levels and related genetic variants are associated with bone mineral density in postmenopausal women[J]. Frontiers in Endocrinology, 2022, 13: 868120.

[11] [11] TARIQ S, TARIQ S, KHALIQ S, et al. Association between vitamin D and resistin in postmenopausal females with altered bone health[J]. Frontiers in Endocrinology, 2020, 11: 615440.

[12] [12] DAVEY SMITH G, HEMAN G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies[J]. Human Molecular Genetics, 2014, 23(R1): R89-98.

[13] [13] VAN DER GRAAF A, CLARINGBOULD A, RIMVERT A, et al. Mendelian randomization while jointly modeling cis genetics identifies causal relationships between gene expression and lipids[J]. Nature Communication, 2020, 11(1): 4930.

[14] [14] ZHU Z, ZHANG F, HU H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets[J]. Nature Genetics, 2016, 48(5): 481-487.

[15] [15] BOWDEN J, HOLMESM V. Meta-analysis and Mendelian randomization: a review[J]. Research Synthesis Methods, 2019, 10(4): 486-496.

[16] [16] SALOMON R, KACZOROWSKI D, VALDERI-MIRA F, et al.Droplet-based single cell RNAseq tools: a practical guide[J]. Lab on a Chip, 2019, 19(10): 1706-1727.

[17] [17] KORSUNSKY I, MILLARD N, FAN J, et al. Fast, sensitive and accurate integration of single-cell data with Harmony[J]. Nature Methods, 2019, 16(12): 1289-1296.

[18] [18] HAO Y, HAO S, ANDERSEN-NISSEN E, et al. Integrated analysis of multimodal single-cell data[J]. Cell, 2021, 184(13): 3573-3587.e29.

[19] [19] SZKLARCZYK D, GABLE A L, NASTOU K C, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets[J]. Nucleic Acids Research, 2021, 49(D1): D605-612.

[20] [20] SHANNON P, MARKIEL A, OZIER O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome Research, 2003, 13(11): 2498-2504.

[21] [21] LIN Q, JOHNS R A. Resistin family proteins in pulmonary diseases[J]. American Journal of Physiology - Lung Cellular and Molecular Physiology, 2020, 319: L422-L434.

[22] [22] ACQUARONE E, MONACELLI F, BORGHI R, et al. Resistin: a reappraisal[J]. Mechanisms of Ageing and Development, 2019, 178: 46-63.

[23] [23] LI Z, WANG X, PAN H, et al. Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-kappaB signaling pathways: implications for intervertebral disc degeneration[J]. Osteoarthritis and Cartilage, 2017, 25(2): 341-350.

[24] [24] LEE S, LEE H C, KWON Y W, et al. Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes[J]. Cell Metabolism, 2014, 19(3): 484-497.

[25] [25] ZHOU L, LI J Y, HE P P, et al. Resistin: potential biomarker and therapeutic target in atherosclerosis[J]. Clinica Chimica Acta; International Journal of Clinical Chemistry, 2021, 512: 84-91.

[26] [26] SATO H, MURAOKA S, KUSUNOKI N, et al. Resistin upregulates chemokine production by fibroblast-like synoviocytes from patients with rheumatoid arthritis[J]. Arthritis Research & Therapy, 2017, 19(1): 263.

[27] [27] ZHANG Z, ZHANG Z, KANG Y, et al. Resistin stimulates expression of chemokine genes in chondrocytes via combinatorial regulation of C/EBPbeta and NF-kappaB[J]. International Journal of Molecular Sciences, 2014, 15(10): 17242-17255.